1. Home
  2. ENOV vs PPTA Comparison

ENOV vs PPTA Comparison

Compare ENOV & PPTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENOV
  • PPTA
  • Stock Information
  • Founded
  • ENOV 1995
  • PPTA 2011
  • Country
  • ENOV United States
  • PPTA United States
  • Employees
  • ENOV N/A
  • PPTA N/A
  • Industry
  • ENOV Fluid Controls
  • PPTA Precious Metals
  • Sector
  • ENOV Industrials
  • PPTA Basic Materials
  • Exchange
  • ENOV Nasdaq
  • PPTA Nasdaq
  • Market Cap
  • ENOV 1.8B
  • PPTA 1.9B
  • IPO Year
  • ENOV 2008
  • PPTA N/A
  • Fundamental
  • Price
  • ENOV $31.80
  • PPTA $24.34
  • Analyst Decision
  • ENOV Strong Buy
  • PPTA Strong Buy
  • Analyst Count
  • ENOV 6
  • PPTA 4
  • Target Price
  • ENOV $51.00
  • PPTA $25.38
  • AVG Volume (30 Days)
  • ENOV 809.0K
  • PPTA 3.2M
  • Earning Date
  • ENOV 11-05-2025
  • PPTA 11-12-2025
  • Dividend Yield
  • ENOV N/A
  • PPTA N/A
  • EPS Growth
  • ENOV N/A
  • PPTA N/A
  • EPS
  • ENOV N/A
  • PPTA N/A
  • Revenue
  • ENOV $2,189,576,000.00
  • PPTA N/A
  • Revenue This Year
  • ENOV $9.13
  • PPTA N/A
  • Revenue Next Year
  • ENOV $6.39
  • PPTA N/A
  • P/E Ratio
  • ENOV N/A
  • PPTA N/A
  • Revenue Growth
  • ENOV 14.40
  • PPTA N/A
  • 52 Week Low
  • ENOV $25.47
  • PPTA $7.81
  • 52 Week High
  • ENOV $49.83
  • PPTA $24.84
  • Technical
  • Relative Strength Index (RSI)
  • ENOV 47.12
  • PPTA 77.91
  • Support Level
  • ENOV $30.24
  • PPTA $19.88
  • Resistance Level
  • ENOV $32.43
  • PPTA $24.84
  • Average True Range (ATR)
  • ENOV 1.00
  • PPTA 1.30
  • MACD
  • ENOV -0.12
  • PPTA 0.46
  • Stochastic Oscillator
  • ENOV 26.45
  • PPTA 93.71

About ENOV Enovis Corporation

Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

About PPTA Perpetua Resources Corp.

Perpetua Resources Corp is focused on the exploration, site restoration, and redevelopment of gold-antimony-silver deposits in the Stibnite-Yellow Pine district of central Idaho that are encompassed by the Stibnite Gold Project. The Project is one of the highest-grade, open-pit gold deposits in the United States and is designed to apply a modern, responsible mining approach to restore an abandoned mine site and produce both gold and the only mined source of antimony in the United States. It has one segment, mineral exploration in the United States.

Share on Social Networks: